Pillar Biosciences has raised $34.5M in funding to advance its innovative solutions. This significant investment will help enhance product development and market reach.
Pillar Biosciences has raised $34.5M in funding to advance its innovative solutions. This significant investment will help enhance product development and market reach.
05/27/25, 4:21 PM
Location
natickMoney raised
$34.5 million
Industry
biotechnology
Pillar Biosciences has successfully raised $34.5 million in its latest funding round. The capital will be utilized to further develop its groundbreaking solutions in the biotechnology space. This funding is expected to accelerate their growth trajectory. The company aims to enhance its market presence significantly with this investment.
Company Info
Location
natick, massachusetts, united states
Additional Info
Pillar Biosciences is the leader in Decision Medicine™, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to generate data that optimizes selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring. Pillar's NGS testing solutions are powered by its proprietary SLIMamp® and PiVAT® technologies, helping to localize the testing process, reduce diagnostic costs and improve access and efficiency of complex NGS testing for clinicians, prescribers, and patients globally. The company has more than 20 NGS testing kits available in IVD or RUO formats, with multiple panels in various stages of development. Pillar Biosciences has operations in Natick, MA.